Zylem Biosciences is a preclinical biotechnology startup, pioneering the development of targeted medicines by employing rational design inspired by nature. Our novel platform technology spans a deep pipeline of therapies applicable to diseases and conditions where lipid dysfunction plays a critical role, including cancer, skin disease, and eye disease. Visit our website to find out more.